Advertisement
Canada markets open in 2 hours 42 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7310
    +0.0012 (+0.17%)
     

  • CRUDE OIL

    82.86
    +0.05 (+0.06%)
     

  • Bitcoin CAD

    86,981.61
    -3,774.84 (-4.16%)
     

  • CMC Crypto 200

    1,348.96
    -33.61 (-2.43%)
     

  • GOLD FUTURES

    2,337.80
    -0.60 (-0.03%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,508.50
    -156.00 (-0.88%)
     

  • VOLATILITY

    16.14
    +0.17 (+1.06%)
     

  • FTSE

    8,090.45
    +50.07 (+0.62%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6813
    -0.0006 (-0.09%)
     

Intellipharmaceutics International, Inc. :I-CA: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017

CapitalCube
Updated
Intellipharmaceutics International, Inc. :I-CA: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017

Categories: Yahoo Finance Get free summary analysis Intellipharmaceutics International, Inc. reports financial results for the quarter ended November 30, 2016. We analyze the earnings along side the following peers of Intellipharmaceutics International, Inc. – Theratechnologies Inc. (TH-CA) that have also reported for this period. Highlights Summary numbers: Revenues of CAD 0.75 million, Net Earnings of CAD -5.19 million. ... Read more (Read more...)

Continue reading